Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-06

Clinical Trial Update: Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children [NA]

View source ↗

Summary

A completed clinical trial comparing sublingual glycine to placebo for attentional difficulties and hyperactivity in prepubertal children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycine (sublingual) (glycine)

Snippet

Sponsor: Eberhard Schulz | Conditions: Motor Activity, Attention Deficit | NA | Status: COMPLETED